Literature DB >> 16895932

COPA--cancer outlier profile analysis.

James W MacDonald1, Debashis Ghosh.   

Abstract

UNLABELLED: Chromosomal translocations are common in cancer, and in some cases may be causal in the progression of the disease. Using microarrays, in which the expression of thousands of genes are simultaneously measured, could potentially allow one to detect recurrent translocations for a particular cancer type. Standard statistical tests, such as the t-test are not suited for detecting these translocations, but a simple test based on robust centering and scaling of the data to help detect outlier samples, followed by a search for pairs of samples with mutually exclusive outliers, may be used to find genes involved in recurrent translocations. We have implemented this method, termed Cancer Outlier Profile Analysis (COPA) in an R package (that we call the copa package), and show its applicability on a publicly available dataset. AVAILABILITY: http://www.bioconductor.org

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895932     DOI: 10.1093/bioinformatics/btl433

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  58 in total

1.  NIRF constitutes a nodal point in the cell cycle network and is a candidate tumor suppressor.

Authors:  Tsutomu Mori; Daisuke D Ikeda; Toshihiko Fukushima; Seiichi Takenoshita; Hideo Kochi
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 2.  Recurrent rearrangements in prostate cancer: causes and therapeutic potential.

Authors:  Nicole M White; Felix Y Feng; Christopher A Maher
Journal:  Curr Drug Targets       Date:  2013-04       Impact factor: 3.465

3.  [Screening key genes associated with the development and progression of non-small cell lung cancer based on gene-enrichment analysis and meta-analysis].

Authors:  Wenwu He; Lei Xian; Yongyong Wang; Yanling Hu; Mingwu Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-07

4.  Identification of novel microRNA regulatory pathways associated with heterogeneous prostate cancer.

Authors:  Yifei Tang; Wenying Yan; Jiajia Chen; Cheng Luo; Antti Kaipia; Bairong Shen
Journal:  BMC Syst Biol       Date:  2013-10-16

Review 5.  Recurrent gene fusions in prostate cancer.

Authors:  Chandan Kumar-Sinha; Scott A Tomlins; Arul M Chinnaiyan
Journal:  Nat Rev Cancer       Date:  2008-06-19       Impact factor: 60.716

6.  Screening key genes and pathways in glioma based on gene set enrichment analysis and meta-analysis.

Authors:  Yanyan Tang; Wenwu He; Yunfei Wei; Zhanli Qu; Jinming Zeng; Chao Qin
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

7.  Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.

Authors:  Yu-Wei Cheng; Kamran Idrees; Richard Shattock; Sajid A Khan; Zhaoshi Zeng; Cameron W Brennan; Philip Paty; Francis Barany
Journal:  Int J Cancer       Date:  2010-08-01       Impact factor: 7.396

8.  Dual KS: Defining Gene Sets with Tissue Set Enrichment Analysis.

Authors:  Yarong Yang; Eric J Kort; Nader Ebrahimi; Zhongfa Zhang; Bin T Teh
Journal:  Cancer Inform       Date:  2010-01-21

9.  A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer.

Authors:  Jean-Philippe Meyniel; Paul H Cottu; Charles Decraene; Marc-Henri Stern; Jérôme Couturier; Ingrid Lebigot; André Nicolas; Nina Weber; Virginie Fourchotte; Séverine Alran; Audrey Rapinat; David Gentien; Sergio Roman-Roman; Laurent Mignot; Xavier Sastre-Garau
Journal:  BMC Cancer       Date:  2010-05-21       Impact factor: 4.430

10.  The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis.

Authors:  Sergio Ruiz; Eugenio Santos; Xosé R Bustelo
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.